TGF-β and IL-10 expression decrease synthesis of IFNγ (Figure 2) and TNF-α by pro-inflammatory CD4 T cells, and in turn reduce tumor-specific cytotoxicity of CTLs, prevent activities of dendritic cells and NK cells, and result in tolerance to tumor cells (73–75). This evidence concerns the gene TGFB1 and neoplasm.